FDA Drug Application (021689) for NEXIUM IV by ASTRAZENECA PHARMS

Back to FDA Applications sponsored by ASTRAZENECA PHARMS

Application Number021689
Product Number001
FormINJECTABLE;INTRAVENOUS
DosageEQ 20MG BASE/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
Reference Drug
Drug NameNEXIUM IV
Active IngredientESOMEPRAZOLE SODIUM

Active IngredientCount
List of drugs with Active Ingredient ESOMEPRAZOLE SODIUM2


Back to FDA Applications sponsored by ASTRAZENECA PHARMS